No Data
No Data
Emerald Resources Establishes Mineral Estimate for Western Australian Project
Emerald Resources Unveils Major Gold Discovery in Australia
FTAC Emerald Acquisition Faces Nasdaq Delisting and Strategic Transition
FTAC Emerald Acquisition Announces Extension of Deadline to Complete Business Combination
Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted For Relutrigine In Dravet Syndrome; Praxis Plans To Initiate An All-DEE Trial (EMERALD), Inclusive Of Dravet Syndrome, In 1H2025
Canaccord Genuity Sticks to Their Buy Rating for Emerald Resources NL (EOGSF)